Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,469Revenue $M198Net Margin (%)-0.5Altman Z-Score9.9
Enterprise Value $M2,418EPS $-0.4Operating Margin %3.4Piotroski F-Score7
P/E(ttm)--Beneish M-Score-2.0Pre-tax Margin (%)-0.3Higher ROA y-yY
Price/Book13.410-y EBITDA Growth Rate %--Quick Ratio1.3Cash flow > EarningsY
Price/Sales11.55-y EBITDA Growth Rate %--Current Ratio1.6Lower Leverage y-yY
Price/Free Cash Flow565y-y EBITDA Growth Rate %--ROA % (ttm)-0.3Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-0.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M36.4ROIC % (ttm)6.9Gross Margin Increase y-yY

Gurus Latest Trades with PCRX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PCRXMariko Gordon 2015-03-31 Reduce-0.12%$85.01 - $119.27
($101.46)
$ 67.75-33%Reduce 4.30%659,998
PCRXGeorge Soros 2015-03-31 Sold Out -0.084%$85.01 - $119.27
($101.46)
$ 67.75-33%Sold Out0
PCRXRon Baron 2015-03-31 Add0.01%$85.01 - $119.27
($101.46)
$ 67.75-33%Add 22.79%82,380
PCRXJoel Greenblatt 2015-03-31 Buy 0.01%$85.01 - $119.27
($101.46)
$ 67.75-33%New holding9,319
PCRXMariko Gordon 2014-12-31 Reduce-0.54%$86.02 - $107.8
($94.65)
$ 67.75-28%Reduce 15.33%689,628
PCRXGeorge Soros 2014-12-31 Buy 0.08%$86.02 - $107.8
($94.65)
$ 67.75-28%New holding87,000
PCRXJoel Greenblatt 2014-12-31 Sold Out -0.01%$86.02 - $107.8
($94.65)
$ 67.75-28%Sold Out0
PCRXKen Fisher 2014-12-31 Buy $86.02 - $107.8
($94.72)
$ 67.75-28%New holding4,800
PCRXMariko Gordon 2014-09-30 Reduce-1.21%$83.31 - $108.26
($97.65)
$ 67.75-31%Reduce 28.09%814,470
PCRXRon Baron 2014-09-30 Reduce-0.03%$83.31 - $108.26
($97.65)
$ 67.75-31%Reduce 59.75%62,139
PCRXJoel Greenblatt 2014-09-30 Reduce$83.31 - $108.26
($97.65)
$ 67.75-31%Reduce 26.78%6,946
PCRXMariko Gordon 2014-06-30 Reduce-0.66%$63.61 - $91.01
($75.89)
$ 67.75-11%Reduce 17.39%1,132,552
PCRXRon Baron 2014-06-30 Add0.05%$63.61 - $91.01
($75.89)
$ 67.75-11%Add 802.88%154,393
PCRXJoel Greenblatt 2014-06-30 Buy 0.01%$63.61 - $91.01
($75.89)
$ 67.75-11%New holding9,486
PCRXMariko Gordon 2014-03-31 Add0.19%$55.83 - $80.43
($67.63)
$ 67.750%Add 5.13%1,371,042
PCRXRon Baron 2014-03-31 Add$55.83 - $80.43
($67.63)
$ 67.750%Add 163.28%17,100
PCRXMariko Gordon 2013-12-31 Add2.08%$47.74 - $56.97
($52.53)
$ 67.7529%Add 203.52%1,304,190
PCRXRon Baron 2013-12-31 Buy $47.74 - $56.97
($52.53)
$ 67.7529%New holding6,495
PCRXMariko Gordon 2013-09-30 Add0.93%$30.01 - $47.47
($36.37)
$ 67.7586%Add 3812.66%429,688
PCRXMariko Gordon 2013-06-30 Buy 0.02%$25.84 - $30.26
($28.93)
$ 67.75134%New holding10,982
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PCRX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PCRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
STACK DAVID MPresident, CEO and Chairman 2015-04-15Sell25,000$90.5-25.14view
HASTINGS PAUL JDirector 2015-04-10Sell2,500$88-23.01view
Riker Lauren BullaroExecutive Director, Finance 2015-03-16Sell5,000$95.34-28.94view
PACE GARY WDirector 2015-03-13Buy1,000$93.83-27.79view
LONGENECKER JOHN P PHDDirector 2015-03-12Sell3,000$95.28-28.89view
Scibetta James SSVP, CFO 2015-02-06Sell15,000$111.22-39.08view
STACK DAVID MPresident, CEO and Chairman 2015-01-15Sell15,000$97.52-30.53view
HASTINGS PAUL JDirector 2015-01-12Sell2,500$94.06-27.97view
LONGENECKER JOHN P PHDDirector 2014-12-29Sell1,000$93.32-27.4view
WINGER DENNIS LDirector 2014-12-05Buy2,645$94.54-28.34view

Press Releases about PCRX :

Quarterly/Annual Reports about PCRX:

News about PCRX:

Articles On GuruFocus.com
Wedbush Highlights 2015 Catalysts for Emerging BioPharmaceuticals Feb 04 2015 
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Pacira Pharmace Nov 28 2014 
Mariko Gordon's First Quarter Top Five May 15 2014 
Baron Funds Comments on Pacira Pharmaceuticals Mar 05 2014 
comment on PCRX Mar 15 2013 
Weekly CFO Buys Highlight: PCRX, UGI, MIG, GLT, IOSP Feb 27 2011 
Weekly CFO Buys Highlight: REFR, UGI, PCRX, NOIZ Feb 21 2011 
Pacira Pharmaceuticals Inc. (PCRX) CFO James S Scibetta buys 5,000 Shares Feb 16 2011 
Pacira Pharmaceuticals Inc. (PCRX) CEO David M Stack buys 5,000 Shares Feb 11 2011 

More From Other Websites
Should You Get Rid of Pacira Pharmaceuticals (PCRX) Now? - Tale of the Tape Jun 29 2015
Pacira Pharma Investors Require Patience Jun 24 2015
Coverage initiated on Pacira Pharma by Leerink Partners Jun 19 2015
PACIRA PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 03 2015
Pacira-FDA Meet for Exparel's Nerve Block Label Expansion - Analyst Blog May 29 2015
Pacira Pharmaceuticals Announces Completion of End-of-Review Process with FDA Regarding EXPAREL sNDA... May 28 2015
Pacira Pharmaceuticals, Inc. to Present at Investor Conferences in June May 20 2015
Pacira Pharmaceuticals, Inc. to Present at Investor Conferences in June May 20 2015
Pacira Announces New Data Supporting Clinical and Pharmacoeconomic Utility of EXPAREL in Patients... May 19 2015
Pacira Announces New Data Supporting Clinical and Pharmacoeconomic Utility of EXPAREL in Patients... May 19 2015
Pacira Pharmaceuticals, Inc. to Present at the Bank of America Merrill Lynch 2015 Health Care... May 07 2015
Pacira Pharmaceuticals, Inc. to Present at the Bank of America Merrill Lynch 2015 Health Care... May 07 2015
PACIRA PHARMACEUTICALS, INC. Financials May 06 2015
10-Q for Pacira Pharmaceuticals, Inc. May 04 2015
Pacira Down on Revenue Miss in Q1, Beat on Earnings - Analyst Blog May 04 2015
Pacira Pharmaceuticals (PCRX): Moving Average Crossover Alert - Tale of the Tape Apr 30 2015
Pacira Pharmaceuticals Inc Earnings Call scheduled for 9:00 am ET today Apr 30 2015
PACIRA PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Apr 30 2015
Q1 2015 Pacira Pharmaceuticals Inc Earnings Release - Before Market Open Apr 30 2015
Pacira Pharmaceuticals, Inc. Reports First Quarter EXPAREL Revenues of $56.0 Million and First... Apr 30 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK